Viking Global Investors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,597,460
| Closed | -$93.6M | – | 93 |
|
|
2025
Q2 | $93.6M | Sell |
2,597,460
-7,966,479
| -75% | -$264M | 0.27% | 69 |
|
|
2025
Q1 | $329M | Sell |
10,563,939
-1,643,946
| -13% | -$52.1M | 1.04% | 40 |
|
|
2024
Q4 | $311M | Buy |
12,207,885
+113,864
| +0.9% | +$3.02M | 1.01% | 37 |
|
|
2024
Q3 | $342M | Buy |
12,094,021
+123,963
| +1% | +$3.43M | 1.25% | 26 |
|
|
2024
Q2 | $316M | Buy |
11,970,058
+484,511
| +4% | +$13.4M | 1.21% | 28 |
|
|
2024
Q1 | $349M | Buy |
11,485,547
+1,398,130
| +14% | +$41.2M | 1.3% | 25 |
|
|
2023
Q4 | $283M | Buy |
10,087,417
+623,216
| +7% | +$17.1M | 1.04% | 33 |
|
|
2023
Q3 | $257M | Sell |
9,464,201
-386,731
| -4% | -$11.5M | 1.04% | 31 |
|
|
2023
Q2 | $303M | Sell |
9,850,932
-1,353,317
| -12% | -$45.8M | 1.24% | 29 |
|
|
2023
Q1 | $404M | Buy |
11,204,249
+1,195,738
| +12% | +$44.3M | 1.89% | 20 |
|
|
2022
Q4 | $396M | Sell |
10,008,511
-873,083
| -8% | -$36.4M | 1.98% | 20 |
|
|
2022
Q3 | $437M | Sell |
10,881,594
-1,489,100
| -12% | -$63.6M | 2.02% | 18 |
|
|
2022
Q2 | $520M | Buy |
12,370,694
+1,606,222
| +15% | +$65.8M | 2.38% | 15 |
|
|
2022
Q1 | $419M | Buy |
10,764,472
+449,094
| +4% | +$17.6M | 1.7% | 20 |
|
|
2021
Q4 | $411M | Buy |
10,315,378
+6,174,870
| +149% | +$240M | 1.18% | 27 |
|
|
2021
Q3 | $150M | Buy |
4,140,508
+901,854
| +28% | +$35M | 0.41% | 62 |
|
|
2021
Q2 | $133M | Buy |
3,238,654
+1,176,901
| +57% | +$50.1M | 0.4% | 55 |
|
|
2021
Q1 | $89.9M | Sell |
2,061,753
-225,247
| -10% | -$10.7M | 0.27% | 71 |
|
|
2020
Q4 | $114M | Buy |
2,287,000
+338,936
| +17% | +$14.4M | 0.31% | 67 |
|
|
2020
Q3 | $82M | Sell |
1,948,064
-566,921
| -23% | -$24.3M | 0.3% | 65 |
|
|
2020
Q2 | $122M | Buy |
+2,514,985
| New | +$124M | 0.53% | 49 |
|
Other funds holding RPRX
